Effects of ursolic acid on sub-lesional muscle pathology in a contusion model of spinal cord injury

PloS One
Gregory E BigfordJohn R Bethea

Abstract

Spinal Cord Injury (SCI) results in severe sub-lesional muscle atrophy and fiber type transformation from slow oxidative to fast glycolytic, both contributing to functional deficits and maladaptive metabolic profiles. Therapeutic countermeasures have had limited success and muscle-related pathology remains a clinical priority. mTOR signaling is known to play a critical role in skeletal muscle growth and metabolism, and signal integration of anabolic and catabolic pathways. Recent studies show that the natural compound ursolic acid (UA) enhances mTOR signaling intermediates, independently inhibiting atrophy and inducing hypertrophy. Here, we examine the effects of UA treatment on sub-lesional muscle mTOR signaling, catabolic genes, and functional deficits following severe SCI in mice. We observe that UA treatment significantly attenuates SCI induced decreases in activated forms of mTOR, and signaling intermediates PI3K, AKT, and S6K, and the upregulation of catabolic genes including FOXO1, MAFbx, MURF-1, and PSMD11. In addition, UA treatment improves SCI induced deficits in body and sub-lesional muscle mass, as well as functional outcomes related to muscle function, motor coordination, and strength. These findings provide eviden...Continue Reading

References

Jul 1, 1992·The Journal of the American Paraplegia Society·S P ZlotolowW A Bauman
May 1, 1992·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·D E GarlandD A Weinstein
Aug 1, 1986·Developmental Medicine and Child Neurology·R L Lieber
Oct 1, 1986·Medicine and Science in Sports and Exercise·S R DearwaterD Becker
Jul 1, 1995·The Journal of Spinal Cord Medicine·R McGlinchey-BerrothK L Minaker
Jun 1, 1995·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·P D TsitourasW A Bauman
Jan 1, 1994·Physical Therapy·T Gordon, J Mao
Jun 1, 1993·Journal of the Neurological Sciences·J M RoundD A Jones
Sep 25, 1997·Spinal Cord·D J RodriguezF W Clevenger
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·A C McPherron, S J Lee
Jan 24, 1998·Experimental Neurology·C K ThomasB R Bigland-Ritchie
Jan 14, 1999·Journal of Applied Physiology·M J CastroG A Dudley
Sep 14, 1999·European Journal of Applied Physiology and Occupational Physiology·M J CastroG A Dudley
Oct 6, 1999·Current Opinion in Genetics & Development·S J Lee, A C McPherron
Oct 16, 1999·The Journal of Biological Chemistry·R E Rhoads
Sep 30, 2000·Assistive Technology : the Official Journal of RESNA·W A BaumanB J Kemp
Nov 9, 2000·Genes & Development·H ZhangT P Neufeld
Nov 18, 2000·American Journal of Physiology. Cell Physiology·E E Dupont-VersteegdenC A Peterson
Jul 19, 2001·Proceedings of the National Academy of Sciences of the United States of America·S J Lee, A C McPherron
Apr 12, 2002·The Journal of Spinal Cord Medicine·W A Bauman, A M Spungen
Sep 13, 2002·American Journal of Physiology. Cell Physiology·Robert W GrangeJames T Stull
Sep 18, 2002·Journal of Applied Physiology·Robert J TalmadgeV Reggie Edgerton
Jun 18, 2003·Cell·Yigong Shi, Joan Massagué
Aug 12, 2003·Journal of Applied Physiology·Ann M SpungenWilliam A Bauman

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

GraphPad
Prism

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.